The K@W Network:
Drug manufacturers who face large settlements from the opioid crisis could follow the Insys example and file for bankruptcy protection, experts say.
High-deductible employer health plans are cheaper for businesses and may also be cheaper for employees. But are they too much of a gamble?
A lawsuit alleging that 20 generic drug makers colluded to fix prices reveals how existing market-based, competitive mechanisms fail to protect consumers.
Amazon’s move into health care, with HIPAA compliance for virtual assistant Alexa, raises questions about what the tech giant plans to do with patient data.
Government intervention could work where market mechanisms have failed to keep prescription drug prices affordable – but policymakers will have a tough time cutting through the finger-pointing from all sides,[…]